Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: January 3, 2026, 11:07 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 532443 | NSE: CERA

Cera Sanitaryware Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: January 3, 2026, 11:07 am

Market Cap 6,782 Cr.
Current Price 5,258
High / Low 7,680/5,060
Stock P/E28.8
Book Value 1,063
Dividend Yield1.24 %
ROCE22.4 %
ROE18.3 %
Face Value 5.00
PEG Ratio2.99

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Cera Sanitaryware Ltd

Competitors

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Exxaro Tiles Ltd 362 Cr. 8.09 11.0/5.2268.0 6.210.00 %3.49 %0.26 % 1.00
Carysil Ltd 2,611 Cr. 918 1,072/48232.2 1990.26 %15.4 %14.5 % 2.00
Somany Ceramics Ltd 1,656 Cr. 404 652/39229.0 1910.74 %11.5 %8.17 % 2.00
Orient Bell Ltd 446 Cr. 303 350/21568.2 2170.16 %2.38 %0.90 % 10.0
Nitco Ltd 2,271 Cr. 99.1 164/76.5 13.20.00 %42.9 %% 10.0
Industry Average3,526.78 Cr810.9041.68200.530.47%12.44%14.63%6.10

All Competitor Stocks of Cera Sanitaryware Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 414456533427461437547398490449578419488
Expenses 348383445358387377455342420390472366421
Operating Profit 667388687459925670591065367
OPM % 16%16%17%16%16%14%17%14%14%13%18%13%14%
Other Income 1114516111616161812141917
Interest 1121111132212
Depreciation 88888998101010910
Profit before tax 687783757665986375601086172
Tax % 25%27%25%25%25%22%23%25%10%23%21%24%22%
Net Profit 51566356575175476846864757
EPS in Rs 39.0043.3448.3943.3443.7439.1257.6936.1152.7935.5666.3536.0843.92

Last Updated: January 2, 2026, 2:59 am

Below is a detailed analysis of the quarterly data for Cera Sanitaryware Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Sales, as of Sep 2025, the value is 488.00 Cr.. The value appears strong and on an upward trend. It has increased from 419.00 Cr. (Jun 2025) to 488.00 Cr., marking an increase of 69.00 Cr..
  • For Expenses, as of Sep 2025, the value is 421.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 366.00 Cr. (Jun 2025) to 421.00 Cr., marking an increase of 55.00 Cr..
  • For Operating Profit, as of Sep 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Jun 2025) to 67.00 Cr., marking an increase of 14.00 Cr..
  • For OPM %, as of Sep 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Jun 2025) to 14.00%, marking an increase of 1.00%.
  • For Other Income, as of Sep 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Jun 2025) to 17.00 Cr., marking a decrease of 2.00 Cr..
  • For Interest, as of Sep 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Jun 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
  • For Depreciation, as of Sep 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Jun 2025) to 10.00 Cr., marking an increase of 1.00 Cr..
  • For Profit before tax, as of Sep 2025, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Jun 2025) to 72.00 Cr., marking an increase of 11.00 Cr..
  • For Tax %, as of Sep 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Jun 2025) to 22.00%, marking a decrease of 2.00%.
  • For Net Profit, as of Sep 2025, the value is 57.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Jun 2025) to 57.00 Cr., marking an increase of 10.00 Cr..
  • For EPS in Rs, as of Sep 2025, the value is 43.92. The value appears strong and on an upward trend. It has increased from 36.08 (Jun 2025) to 43.92, marking an increase of 7.84.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 5:31 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 6648229171,0111,1821,3441,2091,2021,4421,8031,8711,9151,935
Expenses 5697037768411,0141,1521,0451,0521,2201,5101,5771,6221,649
Operating Profit 95119141171168191164150221293295293285
OPM % 14%14%15%17%14%14%14%12%15%16%16%15%15%
Other Income 651011141514221725595962
Interest 6855534455577
Depreciation 12151618222333333030343939
Profit before tax 82101129158154180141134203282314306301
Tax % 37%33%36%34%35%36%18%25%27%26%24%19%
Net Profit 526883104100115116101149210239246235
EPS in Rs 41.0252.0264.1779.9477.0888.4689.1477.89114.84161.20183.89191.11181.91
Dividend Payout % 12%12%14%15%16%15%15%17%30%31%33%34%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)30.77%22.06%25.30%-3.85%15.00%0.87%-12.93%47.52%40.94%13.81%2.93%
Change in YoY Net Profit Growth (%)0.00%-8.71%3.24%-29.15%18.85%-14.13%-13.80%60.46%-6.59%-27.13%-10.88%

Cera Sanitaryware Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:10%
3 Years:10%
TTM:5%
Compounded Profit Growth
10 Years:14%
5 Years:16%
3 Years:17%
TTM:7%
Stock Price CAGR
10 Years:13%
5 Years:21%
3 Years:6%
1 Year:-32%
Return on Equity
10 Years:18%
5 Years:17%
3 Years:19%
Last Year:18%

Last Updated: September 5, 2025, 1:45 am

Balance Sheet

Last Updated: December 4, 2025, 1:06 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 6666666666666
Reserves 2183454155185986947668689991,1631,3361,3441,364
Borrowings 48683534241833283746406360
Other Liabilities 181224290302320371320381385441443427383
Total Liabilities 4536447478619491,0891,1261,2831,4271,6561,8251,8411,814
Fixed Assets 152215226266279305350330321320356380375
CWIP 58405111111713119
Investments 124867119139212262513567669807702712
Other Assets 284374449475525561512440539649649749718
Total Assets 4536447478619491,0891,1261,2831,4271,6561,8251,8411,814

Below is a detailed analysis of the balance sheet data for Cera Sanitaryware Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
  • For Reserves, as of Sep 2025, the value is 1,364.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,344.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 20.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 60.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 63.00 Cr. (Mar 2025) to 60.00 Cr., marking a decrease of 3.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 383.00 Cr.. The value appears to be improving (decreasing). It has decreased from 427.00 Cr. (Mar 2025) to 383.00 Cr., marking a decrease of 44.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 1,814.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,841.00 Cr. (Mar 2025) to 1,814.00 Cr., marking a decrease of 27.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 375.00 Cr.. The value appears to be declining and may need further review. It has decreased from 380.00 Cr. (Mar 2025) to 375.00 Cr., marking a decrease of 5.00 Cr..
  • For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 2.00 Cr..
  • For Investments, as of Sep 2025, the value is 712.00 Cr.. The value appears strong and on an upward trend. It has increased from 702.00 Cr. (Mar 2025) to 712.00 Cr., marking an increase of 10.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 718.00 Cr.. The value appears to be declining and may need further review. It has decreased from 749.00 Cr. (Mar 2025) to 718.00 Cr., marking a decrease of 31.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 1,814.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,841.00 Cr. (Mar 2025) to 1,814.00 Cr., marking a decrease of 27.00 Cr..

Notably, the Reserves (1,364.00 Cr.) exceed the Borrowings (60.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +63411161127211412326298156228116
Cash from Investing Activity +-48-117-38-92-36-102-76-243-70-101-140128
Cash from Financing Activity +-2576-48-20-34-27-53-13-21-59-80-258
Net Cash Flow-10-130-01-15-677-38-14

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow47.0051.00106.00137.00144.00173.00131.00122.00184.00247.00255.00230.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days597275808381676342383951
Inventory Days1251201099810410112896154167148163
Days Payable4546485850535281104937577
Cash Conversion Cycle1391451371201361291427892112112137
Working Capital Days334347435658663037434465
ROCE %35%32%30%31%26%27%19%16%22%26%25%22%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters54.48%54.48%54.48%54.48%54.48%54.48%54.48%54.41%54.41%54.41%54.41%54.41%
FIIs17.52%18.03%19.44%20.92%20.63%21.93%21.45%22.89%22.17%20.58%17.18%15.83%
DIIs9.37%9.73%9.04%8.38%8.38%6.61%7.30%6.06%6.26%6.93%12.06%13.55%
Public18.64%17.77%17.05%16.26%16.53%16.98%16.79%16.64%17.16%18.06%16.33%16.19%
Others0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.03%0.02%0.02%
No. of Shareholders37,75239,21343,81642,31634,87834,80433,1231,78,7141,65,5761,56,9051,52,0961,47,987

Shareholding Pattern Chart

No. of Shareholders

Cera Sanitaryware Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HSBC Small Cap Fund 338,650 1.16 187.51N/AN/AN/A
Canara Robeco Small Cap Fund 304,497 1.29 168.6218,8232025-12-07 15:33:4839.15%
UTI Value Fund 108,291 0.59 59.96N/AN/AN/A
UTI Small Cap Fund 69,170 0.79 38.3N/AN/AN/A
Bandhan Flexi Cap Fund 65,002 0.46 35.9940,0022025-12-14 02:09:3662.5%
Tata India Consumer Fund 59,631 1.23 33.0255,6912025-12-15 06:58:387.07%
Edelweiss Small Cap Fund 55,965 0.58 30.99N/AN/AN/A
UTI Dividend Yield Fund 40,941 0.58 22.67N/AN/AN/A
UTI ELSS Tax Saver Fund 36,418 0.53 20.16N/AN/AN/A
Tata Housing Opportunities Fund 19,804 2.07 10.97N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 190.40183.76161.01116.1877.48
Diluted EPS (Rs.) 190.40183.76161.01116.1877.48
Cash EPS (Rs.) 224.36213.65187.35142.51107.24
Book Value[Excl.RevalReserv]/Share (Rs.) 1049.481044.56909.79791.48679.28
Book Value[Incl.RevalReserv]/Share (Rs.) 1049.481044.56909.79791.48679.28
Revenue From Operations / Share (Rs.) 1493.421445.061386.691111.68941.37
PBDIT / Share (Rs.) 279.40278.93252.61194.05140.87
PBIT / Share (Rs.) 247.87250.83227.54169.13110.45
PBT / Share (Rs.) 240.90245.16219.04160.66102.97
Net Profit / Share (Rs.) 192.83185.55162.27117.6076.82
NP After MI And SOA / Share (Rs.) 191.10183.77161.01116.1877.48
PBDIT Margin (%) 18.7019.3018.2117.4514.96
PBIT Margin (%) 16.5917.3516.4015.2111.73
PBT Margin (%) 16.1316.9615.7914.4510.93
Net Profit Margin (%) 12.9112.8411.7010.578.16
NP After MI And SOA Margin (%) 12.7912.7111.6110.458.23
Return on Networth / Equity (%) 18.2017.7517.8514.8811.56
Return on Capital Employeed (%) 21.4322.2623.0619.6614.29
Return On Assets (%) 13.2312.9512.489.737.31
Long Term Debt / Equity (X) 0.000.000.000.010.02
Total Debt / Equity (X) 0.010.010.020.020.05
Asset Turnover Ratio (%) 1.041.071.121.030.96
Current Ratio (X) 3.823.743.242.682.42
Quick Ratio (X) 2.722.792.272.011.88
Inventory Turnover Ratio (X) 4.980.670.760.720.41
Dividend Payout Ratio (NP) (%) 31.6527.2021.7311.180.00
Dividend Payout Ratio (CP) (%) 27.1723.5918.809.210.00
Earning Retention Ratio (%) 68.3572.8078.2788.820.00
Cash Earning Retention Ratio (%) 72.8376.4181.2090.790.00
Interest Coverage Ratio (X) 48.1062.3254.3247.7918.83
Interest Coverage Ratio (Post Tax) (X) 34.4042.7236.7231.0511.27
Enterprise Value (Cr.) 7272.808811.028314.106496.105152.10
EV / Net Operating Revenue (X) 3.784.694.614.494.21
EV / EBITDA (X) 20.1824.2925.3125.7428.12
MarketCap / Net Operating Revenue (X) 3.784.694.604.474.15
Retention Ratios (%) 68.3472.7978.2688.810.00
Price / BV (X) 5.376.557.086.375.83
Price / Net Operating Revenue (X) 3.784.694.604.474.15
EarningsYield 0.030.020.020.020.01

After reviewing the key financial ratios for Cera Sanitaryware Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 190.40. This value is within the healthy range. It has increased from 183.76 (Mar 24) to 190.40, marking an increase of 6.64.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 190.40. This value is within the healthy range. It has increased from 183.76 (Mar 24) to 190.40, marking an increase of 6.64.
  • For Cash EPS (Rs.), as of Mar 25, the value is 224.36. This value is within the healthy range. It has increased from 213.65 (Mar 24) to 224.36, marking an increase of 10.71.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,049.48. It has increased from 1,044.56 (Mar 24) to 1,049.48, marking an increase of 4.92.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,049.48. It has increased from 1,044.56 (Mar 24) to 1,049.48, marking an increase of 4.92.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,493.42. It has increased from 1,445.06 (Mar 24) to 1,493.42, marking an increase of 48.36.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 279.40. This value is within the healthy range. It has increased from 278.93 (Mar 24) to 279.40, marking an increase of 0.47.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 247.87. This value is within the healthy range. It has decreased from 250.83 (Mar 24) to 247.87, marking a decrease of 2.96.
  • For PBT / Share (Rs.), as of Mar 25, the value is 240.90. This value is within the healthy range. It has decreased from 245.16 (Mar 24) to 240.90, marking a decrease of 4.26.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 192.83. This value is within the healthy range. It has increased from 185.55 (Mar 24) to 192.83, marking an increase of 7.28.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 191.10. This value is within the healthy range. It has increased from 183.77 (Mar 24) to 191.10, marking an increase of 7.33.
  • For PBDIT Margin (%), as of Mar 25, the value is 18.70. This value is within the healthy range. It has decreased from 19.30 (Mar 24) to 18.70, marking a decrease of 0.60.
  • For PBIT Margin (%), as of Mar 25, the value is 16.59. This value is within the healthy range. It has decreased from 17.35 (Mar 24) to 16.59, marking a decrease of 0.76.
  • For PBT Margin (%), as of Mar 25, the value is 16.13. This value is within the healthy range. It has decreased from 16.96 (Mar 24) to 16.13, marking a decrease of 0.83.
  • For Net Profit Margin (%), as of Mar 25, the value is 12.91. This value exceeds the healthy maximum of 10. It has increased from 12.84 (Mar 24) to 12.91, marking an increase of 0.07.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.79. This value is within the healthy range. It has increased from 12.71 (Mar 24) to 12.79, marking an increase of 0.08.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 18.20. This value is within the healthy range. It has increased from 17.75 (Mar 24) to 18.20, marking an increase of 0.45.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 21.43. This value is within the healthy range. It has decreased from 22.26 (Mar 24) to 21.43, marking a decrease of 0.83.
  • For Return On Assets (%), as of Mar 25, the value is 13.23. This value is within the healthy range. It has increased from 12.95 (Mar 24) to 13.23, marking an increase of 0.28.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.04. It has decreased from 1.07 (Mar 24) to 1.04, marking a decrease of 0.03.
  • For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has increased from 3.74 (Mar 24) to 3.82, marking an increase of 0.08.
  • For Quick Ratio (X), as of Mar 25, the value is 2.72. This value exceeds the healthy maximum of 2. It has decreased from 2.79 (Mar 24) to 2.72, marking a decrease of 0.07.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.98. This value is within the healthy range. It has increased from 0.67 (Mar 24) to 4.98, marking an increase of 4.31.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.65. This value is within the healthy range. It has increased from 27.20 (Mar 24) to 31.65, marking an increase of 4.45.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.17. This value is within the healthy range. It has increased from 23.59 (Mar 24) to 27.17, marking an increase of 3.58.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 68.35. This value is within the healthy range. It has decreased from 72.80 (Mar 24) to 68.35, marking a decrease of 4.45.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.83. This value exceeds the healthy maximum of 70. It has decreased from 76.41 (Mar 24) to 72.83, marking a decrease of 3.58.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 48.10. This value is within the healthy range. It has decreased from 62.32 (Mar 24) to 48.10, marking a decrease of 14.22.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 34.40. This value is within the healthy range. It has decreased from 42.72 (Mar 24) to 34.40, marking a decrease of 8.32.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 7,272.80. It has decreased from 8,811.02 (Mar 24) to 7,272.80, marking a decrease of 1,538.22.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
  • For EV / EBITDA (X), as of Mar 25, the value is 20.18. This value exceeds the healthy maximum of 15. It has decreased from 24.29 (Mar 24) to 20.18, marking a decrease of 4.11.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
  • For Retention Ratios (%), as of Mar 25, the value is 68.34. This value is within the healthy range. It has decreased from 72.79 (Mar 24) to 68.34, marking a decrease of 4.45.
  • For Price / BV (X), as of Mar 25, the value is 5.37. This value exceeds the healthy maximum of 3. It has decreased from 6.55 (Mar 24) to 5.37, marking a decrease of 1.18.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
  • For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Cera Sanitaryware Ltd as of January 5, 2026 is: ₹4,537.52

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of January 5, 2026, Cera Sanitaryware Ltd is Overvalued by 13.70% compared to the current share price ₹5,258.00

Intrinsic Value of Cera Sanitaryware Ltd as of January 5, 2026 is: ₹4,974.75

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of January 5, 2026, Cera Sanitaryware Ltd is Overvalued by 5.39% compared to the current share price ₹5,258.00

Last 5 Year EPS CAGR: 9.64%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 25.92%, which is a positive sign.
  2. The company has higher reserves (817.54 cr) compared to borrowings (41.08 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (185.62 cr) and profit (191.15 cr) over the years.
  1. The stock has a high average Working Capital Days of 47.08, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 123.25, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cera Sanitaryware Ltd:
    1. Net Profit Margin: 12.91%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 21.43% (Industry Average ROCE: 12.44%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 18.2% (Industry Average ROE: 14.63%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 34.4
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.72
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 28.8 (Industry average Stock P/E: 41.68)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Cera Sanitaryware Ltd. is a Public Limited Listed company incorporated on 17/07/1998 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L26910GJ1998PLC034400 and registration number is 034400. Currently Company is involved in the business activities of Manufacture of other pumps, compressors, taps and valves etc.. Company's Total Operating Revenue is Rs. 1915.25 Cr. and Equity Capital is Rs. 6.45 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Ceramics/Tiles/Sanitaryware9, GIDC Industrial Estate, Mehsana Dist. Gujarat 382715Contact not found
Management
NamePosition Held
Mr. Vikram SomanyChairman & Managing Director
Mrs. Deepshikha KhaitanVice Chairman & Jt Manag. Dir.
Mr. Anupam GuptaExecutive Director -Technical
Mr. Surendra Singh BaidIndependent Director
Ms. Akriti JainIndependent Director
Mr. Ravi BhamidipatyIndependent Director
Mr. Anandh SundarIndependent Director

FAQ

What is the intrinsic value of Cera Sanitaryware Ltd?

Cera Sanitaryware Ltd's intrinsic value (as of 04 January 2026) is ₹4537.52 which is 13.70% lower the current market price of ₹5,258.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,782 Cr. market cap, FY2025-2026 high/low of ₹7,680/5,060, reserves of ₹1,364 Cr, and liabilities of ₹1,814 Cr.

What is the Market Cap of Cera Sanitaryware Ltd?

The Market Cap of Cera Sanitaryware Ltd is 6,782 Cr..

What is the current Stock Price of Cera Sanitaryware Ltd as on 04 January 2026?

The current stock price of Cera Sanitaryware Ltd as on 04 January 2026 is ₹5,258.

What is the High / Low of Cera Sanitaryware Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Cera Sanitaryware Ltd stocks is ₹7,680/5,060.

What is the Stock P/E of Cera Sanitaryware Ltd?

The Stock P/E of Cera Sanitaryware Ltd is 28.8.

What is the Book Value of Cera Sanitaryware Ltd?

The Book Value of Cera Sanitaryware Ltd is 1,063.

What is the Dividend Yield of Cera Sanitaryware Ltd?

The Dividend Yield of Cera Sanitaryware Ltd is 1.24 %.

What is the ROCE of Cera Sanitaryware Ltd?

The ROCE of Cera Sanitaryware Ltd is 22.4 %.

What is the ROE of Cera Sanitaryware Ltd?

The ROE of Cera Sanitaryware Ltd is 18.3 %.

What is the Face Value of Cera Sanitaryware Ltd?

The Face Value of Cera Sanitaryware Ltd is 5.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Cera Sanitaryware Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE